about
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Read More
36.14
0.43
(1.20%)
1.2M
XNAS Volume
XNAS 18 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Kodiak Sciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..